| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |